Moleculin Biotech is trading 5.01% up at $0.62, based on the provided live price at 9:57 a.m. EST on August 21, 2026; no company-specific announcement dated August 21 explains the move.
- Its latest update, published August 14, reported second-quarter results and continued MIRACLE trial progress, including encouraging remission data.
- The update’s direct connection to today’s gain is unconfirmed, while biotech-sector weakness does not explain the contrarian advance.